Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) saw a significant growth in short interest in July. As of July 15th, there was short interest totalling 680,200 shares, a growth of 14.6% from the June 30th total of 593,600 shares. Currently, 6.0% of the shares of the company are short sold. Based on an average […]